The stock of the state-owned e-commerce firm was trading at its highest level since listing on March 29, 2019. In the last 12 trading days, it has soared 91 per cent, as compared to a 3.3 per cent rise in the S&P BSE Sensex.

Polycab India surged 7 per cent to Rs 915, surpassing its previous high recorded on October 30 in the intra-day trade. In the past one month, the stock has rallied 32 per cent against an eight per cent gain in the S&P BSE Sensex.

Shares of Jindal Steel & Power (JSPL) hit an over four-month high of Rs 150, up 11 per cent on the BSE on Thursday on expectation of raw material benefits led by lower coking coal costs to offset the decline in steel prices in the near term.

The stock of the steel company was trading at its highest level since June 27, 2019. It has rallied 60 per cent in the past one month.

Shares of MSTC zoomed 20 per cent to Rs 148 on the BSE on Thursday after the construction & engineering giant Larsen & Toubro (L&T) appointed the company as its selling agent.

The stock of the state-owned e-commerce firm was trading at its highest level since listing on March 29, 2019. In the past nine trading days, it soared 56 per cent, as compared to a four per cent rise in the S&P BSE Sensex. The stock has more than doubled from its recent low price of Rs 70, touched on August 14 in the intra-day deal.

“The United States Food and Drug Administration (US FDA) inspected Unit V, API manufacturing facility at Pashamylaram, Hyderabad and Unit VIII, API manufacturing facility at Gaddapotharam, Hyderabad of the Company from 21st to 28th October 2019 and from 21st to 25th October 2019, respectively. At the end of the inspections, we have been issued a 'Form 483' with 4 observations for each facility,” Aurobindo Pharma said in a regulatory filing.

The 30-share Sensex rose over 666 points before settling at 581.64, or 1.48% higher at 39,831.84. It hit an intra-day high of 39,917.01 and a low of 39,254.12.

SBI was trading 3 per cent higher at Rs 290, up 9 per cent in four days on the NSE. The September quarter was mostly full of positives for SBI as the quarter saw improvement in the bank’s asset quality as slippages halved and net interest margin (NIM) and provision coverage ratio (PCR) expanded further.

According to reports, the brokerage sees "limited risk" in the stock and believes the "company has a lot to gain from a strategic partner". If the divestiture fails, there could be risks to market price, it said.

At 09:15 am, around 101.87 million equity shares, representing 5 per cent of total equity of HDFC Life, changed hands via block deals on the BSE, the exchange data shows. The name of the buyers and sellers were not ascertained immediately.